Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0175)

Milan 20133

2 studies enrolling now · 2 studies all time

What they study most

Lung Neoplasm, Lung Neoplasm Malignant

Studies at this site

• Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I) — Recruiting now
• Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) — Recruiting now